NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synap Biotech

Synap Biotech

Private
Norfolk, VirginiaHealthcare & Life Scienceshttps://www.synapbio.com/

Last Round

Seed

Jun 1, 2026

Total Funding Raised

$115,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Synap Biotech is a biotechnology company developing intranasal nanobody therapies designed to promote neurological recovery following brain injuries such as strokes and traumatic brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanobody therapyintranasal drug deliveryneurological recoveryneuroplasticityNogo-A inhibitortraumatic brain injuryTBIblood-brain barrierneurodegenerative diseasebiotech drug discoverybrain repairCNS therapeuticsregenerative medicinebiopharma licensingbrain injury treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synap Biotech Comps

Public and private peers based on sector, stage, and business model.

Synap Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synap Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 1, 2026

Key People

Founding team and executive leadership

Brent Buchine

Co-Founder And Chief Business Officer (CBO), Co-Founder And Interim CEO

Founding Team

Glenn Block

Co-Founder, President & CEO

Founding Team

Synap Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 88% MoM.

  • Jan 20, 2026

    Monthly visitors increased 655% MoM.

Synap Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synap Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synap Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorfolk, Virginia
Employee Range3
Year Founded2023
Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.